"For some reason modern medicine has itself turned a corner and entered a darkness and is now committing crimes against humanity unequalled
in the history of our race."
 
--Dr. Mark Sircus
NATURAL HEALING 
featuring 
Alternative Cancer Treatments

INTRODUCTION: by DIANNE JACOBS THOMPSON (under construction)
1979 Around January of that year, I went home to die.   ..cont. 
I was diagnosed with stage 2 stomach cancer, chronic bronchitis, acutely infected ovarian cysts, arthritis, sciatica, low thyroid, anemia and a heart condition. Besides that I had chronic ear infections and long-standing clinical depression. The late Dr. Harold Dick, N.D., known as a "naturopathic oncology pioneer" cured me in 5 weeks. It required the diagnosis (the Carroll Food Test) of digestive enzyme deficiency food intolerances which most people have and few know about, and it also identified the primary tissue salt deficiency, along with treatment with glandular protomorphogens to restore glandular health, and Constitutional Hydrotherapy to bring about detoxification, to stimulate blood circulation and the activity of the vital organs and to jump-start the immune system. It turned out to be the basic foundation of the most successful healing system I've ever witnessed.
1986 My 5-year-old daughter was forcibly vaccinated and immediately developed a flesh-eating infection so virulent that my husband and I became infected from contact. Naturopathic medicine brought us back from the brink.
Later that year we were introduced to escharotic cancer salves and treated a dog tumor, my husband's cirrhosis of the liver, various skin lesions, moles, fungal infections, and a lump in my thigh. It eventually helped clear up the remaining symptoms from my husband's flesh-eating infection after he was forced to submit to antibiotic treatment which made a mess of it. There was much more, gallbladder problems in 1999, adrenal deficiency 2001, injury in 2002, arthritis, diabetes, and other issues between 2003-2012, including glaucoma--cured.

This is why I research and write about alternative medicine. It's a debt.

Please help support this website by purchasing hand-fired glass beads and jewelry at nitabeads1 to assist in covering the costs of books, reports, & articles needed for continuing research.


 

 

 

 


 

 

 


*
Alternative treatments for cancer, chronic-degerative disease, infection, stress, harmful emotions and other disorders and conditions;
*Information about junk science and bad medicine, including unsafe and ineffective vaccines and undiagnosed medical conditions mimicking child abuse and Shaken Baby Syndrome;

Natural Healing Information
This site provides starting points. The rest of the journey must be yours.

"Truth wears no mask, seeks neither place nor applause, 
bows to no human shrine; she only asks a hearing"


SUBJECT: "PROGRAMMED CANCER CELL DEATH" --CHML TREATMENT

The CHML Treatment-- "programmed cancer cell death."

A review from the Eclectic Medicine International (EMI) staff at http://www.holisticcancersolutions.com/ 

GLORY PHARMACEUTICALS:

"This is another breakthrough cancer therapy. It is very new, based on recent biological discoveries. We have talked to patients whose inoperable tumors were reduced 65-70% within a few weeks. According to the information below, the treatment is non-toxic, benign, and very effective.

GENERAL INFORMATION
To eliminate every malignant cell, an anticancer drug must overcome
many formidable obstacles presented by a tumor mass.

The drug must travel through the tumor’s intricate network of blood vessels
and disperse through the vessel walls into the interstitum – an area inside
the tumor that is rich in a tough connective tissue protein called collagen.
From there, the drug must enter directly into cancer cells, which typically
occupy less than 50% of the total volume of a tumor.

Unfortunately, the cancer cell has an abundance of defense mechanisms to
block the full penetration of chemotherapeutic agents.

What makes CHML different, is that its molecule is 33,000 times smaller
than normal cells, enabling it's penetration into the tumor mass. But more
importantly, this facilitates its permeation directly into the cancer cell itself.
Once it enters the cell, CHML is able to induce apoptosis (or "programmed
cancer cell death.").
Apoptosis programs cancer cells to commit suicide.
CHML has been called a biological, "cancer seeking missile". It is patented
worldwide, and currently is under evaluation in the United States for cancer
therapy.
Over 500 patients received so far CHML treatments. Many of them were late stage patients. Usually, these patients have exhausted a broad range of conventional and/or alternative cancer treatments. Those with a history of significant conventional intervention are normally the most difficult to treat. However, even in these cases, CHML has been successful.

Most importantly, CHML treatment has been accompanied by virtually none of the side effects commonly associated with cancer chemotherapy.

CHML may be administered by: IV drip, local injection, or by a sophisticated
new technology which allows area-specific, concentrated drug delivery. Using
DSA (Digital Subtraction Angiography), CHML is delivered directly to a site
of major concern by Arterial Infusion.

Used regularly in Cardiology practice, this technology is capable of delivering
concurrent imaging of the intricate blood vessel network of a tumor. DSA is
used to guide the delivery of CHML, as well as measure the immediate effects
on the tumors blood supply network.


***********************************************

Glory Pharmaceuticals
"Working to provide restored health and a new future -
for individuals dealing with a terminal diagnoses. . ."


Scientific Background

Cell death was once thought to be a passive non-specific event, but is now known to be an active biochemical process. Scientists have discovered that any cells have the ability to die by this process, called programmed cell death or apoptosis.

A number of important human diseases are caused by abnormal apoptosis control mechanisms, which can result in either a pathological increase in the number of cells (e.g. cancer) or a damaging loss of cells (e.g. degenerative diseases). Recent data has shown that cells have a discrete cell death pathway defined by a specific set of genes. These genes encode proteins that form the biochemical process that ultimately invokes cell death.

The key genes that control the cell death process are the cell death effectors of the CED-3/ICE ("caspase") family and the cell death inhibitors of the Bcl-2 family. The caspase gene family encodes a set of proteases responsible for carrying out the death process. In a living cell, these proteases are normally kept inactive by proteins encoded by the Bcl-2 family.

Small molecule drugs, like CHML, are able to specifically modulate the activity of the caspase family, the Bcl-2 family, or other key points in the apoptotic pathway, and exert control over the cell death process and have utility in diseases characterized by either excessive or insufficient levels of apoptosis.

The caspases are a family of proteases responsible for carrying out the cell death process. In a living cell, these proteases are kept inactive by proteins on the mitochondrial cell surface from the BcL-2 family. When a cell is exposed to cell death signals such as ischemia, chemotherapy or radiation, BcL-2 function is blocked and caspase activators initiate the cell death cascade.

CHML is able to specifically modulate key points in the apoptotic pathway.

Specific Mechanism:
p53 protein, commonly referred to as "the tumor suppressor gene," is a key player in the cellular apoptosis process. Bio-therapeutic activation of this pathway has been a popular target for recent drug discovery technology.

p53, Bax and p21 protein levels were measured by immunoblotting assay, in MCF-7, ML-1, H1299 (human lung carcinoma) and RKO (human colon cancer,) cell lines after treatment with CHML. p53 protein was found to be elevated in the MCF-7, RKO and ML-1 cells.

As the ability to induce apoptosis is not limited to p53 positive cell lines, it appears that CHML is able to provoke apoptosis through both p53-dependant and -independent pathways.

Core Technologies:
Supporting GLORY's drug discovery program, is a sophisticated new technology for drug administration. Arterial Infusion using DSA is a fast developing science, administered by trained Interventional Radiologists. Formerly used in the management of Cardiology related conditions, the technology is capable of delivering concentrated drugs to a highly specific site (e.g. tumor,) via the arterial network.
Diagnostics:
DSA is capable of delivering concurrent imaging of the intricate vasculature of the tumoral network. This is used to guide the delivery of CHML, as well as measure the immediate effects on the tumor's blood supply network.

In recent studies, CHML was able to effect significant disruptions to the tumoral vasculature network in a number of various malignancies. In virtually every case, marked destruction of the tumor's feeding system could be observed in less than 30 minutes.

These data provide further corroboration of CHML's ability to penetrate a number of difficult tumors."

The CHML treatment is available in an offshore clinic.
The present cost of the full treatment, that lasts one to three months, is approx. $25,000.

For Information contact:
Sean A. Cohen,
11500 Silvergate Dr.
Dublin, CA 94568-2707

Phone: (925) 828-5093

Send mail to:
International Business Offices
Glory Pharmaceuticals
4020 Washington Blvd, Suite 309
Arlington, VA 22201

Phone: (703) 204-2657
Fax: (703) 204-2658





Dianne Jacobs Thompson  Est. 2003
Also http://legaljustice4john.com
The Misdiagnosis of "Shaken Baby Syndrome" --an unproven theory without scientific support, now in disrepute and wreaking legal and medical havoc world-wide
Author publication: NEXUS MAGAZINE "Seawater--A Safe Blood Plasma Substitute?"

DISCLAIMER: The material on this site is for informational and educational purposes only. Please consult with your health care provider for treatment advice.

EMAIL: Truthquest2


Fight Spam! Click Here!